MARSHALL WACE, LLP - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 135 filers reported holding ANI PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.30 and the average weighting 0.1%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$5,172,741
+837.9%
89,093
+769.5%
0.01%
+900.0%
Q2 2023$551,542
+24.0%
10,246
-8.5%
0.00%0.0%
Q1 2023$444,824
-78.4%
11,199
-74.9%
0.00%
-75.0%
Q4 2021$2,055,000
+28.9%
44,600
+97.3%
0.00%
-50.0%
Q1 2019$1,594,000
+51.8%
22,606
+21.7%
0.01%
+100.0%
Q3 2018$1,050,00018,5780.00%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Healthcare Value Capital, LLC 200,000$13,270,00021.02%
Healthcare Value Capital, LLC 50,000$3,318,0005.26%
Consonance Capital Management LP 653,258$43,344,0004.17%
1492 Capital Management LLC 34,500$2,289,0001.87%
JW Asset Management, LLC 29,722$1,972,0001.36%
FRANKLIN STREET ADVISORS INC /NC 29,000$1,924,0000.35%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 55,705$3,696,0000.27%
Ativo Capital Management LLC 15,805$1,049,0000.24%
DIKER MANAGEMENT LLC 9,810$651,0000.23%
CASTLEARK MANAGEMENT LLC 100,615$6,676,0000.20%
View complete list of ANI PHARMACEUTICALS INC shareholders